The influence of antithrombin III (AT III) substitution to supranormal activities on systemic procoagulant turnover in patients with end-stage chronic liver disease. - Scherer,R.; Kabatnik,M.; Erhard,J.; Peters,J. (Intensive Care Med, 1997)